This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Northwest Kidney Centers Launches Capital Campaign For $5 Million Comprehensive Kidney Resource Center

SEATTLE, April 19, 2012 /PRNewswire/ -- Northwest Kidney Centers has launched a campaign to raise $1.5 million of the $5 million needed to turn its 700 Broadway building into a comprehensive kidney resource center. The center supports the three key areas of the nonprofit's mission – patient care, education and research.

Northwest Kidney Centers, which is celebrating its 50th anniversary as the first dialysis organization in the world – has already raised $1.25 million thanks to early gifts.

A lead gift of $450,000 was made from the estate of John and Susie Morganti, long-time supporters of the organization. PACCAR Inc, a supporter of Northwest Kidney Centers for 46 years, donated $100,000.

"This new comprehensive kidney resource center – unique in the United States – will house an array of patient-focused services," said Joyce F. Jackson, chief executive and president of Northwest Kidney Centers. "In addition to an updated community dialysis clinic, the center will house our expanded kidney-specialty pharmacy and a clinical research center for kidney research."

The building also will include three new conference rooms, an education and training center for new dialysis patients, and a demonstration kitchen to expand teaching and learning opportunities for patients, families, physicians and the community.

The first floor will include a Heritage Gallery showcasing important artifacts that illustrate Northwest Kidney Centers' standing as the first out-of-hospital dialysis provider in the world.

"We want this to be a valuable resource for all of our patients and their families – a place where they can learn about ways to improve their health and manage their disease," Jackson said.

The new facility benefits people who face the epidemic of chronic kidney disease, which affects one in seven American adults.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.03 -2.90%
FB $116.73 7.20%
GOOG $691.02 -2.10%
TSLA $247.54 -1.60%
YHOO $36.59 -0.97%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs